“…A wealth of data has subsequently shown similar effects following administration of DA agonists, and these effects are blocked by neurotoxic 6-OHDA lesions in the mesolimbic DA system (for example, Kelly & Iversen, 1976) and by DA antagonists (Pijnenburg et al, 1976;Pijnenburg, Honig, & Van Rossum, 1975). Repeated exposure to MDMA (Ball, Budreau, & Rebec, 2006;Ball, Klein, Plocinski, & Slack, 2011;Ball, Wellman, Fortenberry, & Rebec, 2009;Ball, Wellman, Miller, & Rebec, 2010;Bradbury, Gittings, & Schenk, 2012;Colussi-Mas & Schenk, 2008;Kalivas et al, 1998;Lettfuss, Seeger-Armbruster, & von Ameln-Mayerhofer, 2013;Ludwig, Mihov, & Schwarting, 2008;McCreary, Bankson, & Cunningham, 1999;Modi, Yang, Swann, & Dafny, 2006), produced an augmented horizontal activity response following some dosing regimens, corresponding with an enhanced DA response (Kalivas et al, 1993;Kalivas & Stewart, 1991;Sorg & Kalivas, 1991). Enhanced synaptic DA also underlies increased vertical activity (rearing), although relatively fewer investigations of the neurochemical underpinnings of this behaviour have been conducted.…”